The aim of WSPHA association is to foster constructive scientific interactions and collaborations among the top worldwide experts on Pulmonary Hypertension. The authoritative profile of its founders places WSPHA in a pivotal position of the sector.
The aim of the World Symposia on Pulmonary Hypertension Association (WSPHA) is to foster constructive scientific interactions and collaborations among the top worldwide experts on Pulmonary Hypertension, patients, industry, regulators and other stakeholders.
The WSPHA has been created with the purpose of intensifying scientific research and disseminate medical knowledge in the field of pulmonary hypertension.
The Association will organise working meetings including the Scientific Board members and additional experts when considered appropriate. Scientific meetings will prioritize specific topics of clinical and basic science relevance.
WSPHA may fund Research Projects, Research Fellowships and Junior Scholarships focused on hot topics for WSPH.
There will be a particular attention on developing emerging leaders in the field of pulmonary circulation.
The Association will organise the next PH World Congresses, as the four founding members have done over the past twenty years.
The growing interest in Pulmonary Hypertension is confirmed by the presence of an increasing number of specialists at the World Congresses. In fact, participants have almost increased fourfold in the last ten years. The first Congress was held in Geneva in 1973 and was attended by 17 participants. They rose to 85 in Evian in 1998. There were 100 members of multidisciplinary medical teams and 200 specialists in Venice in 1998, rising respectively to 120 and 350 in 2008, 129 and 1.070 in Nice in 2013 and 124 and 1.376 again in Nice, in 2018.